Loading organizations...
Key people at Helix Fund.
Helix Fund was founded in 2004 by David A. Helfand (Founder and CEO).
Helix Fund functions as an early-stage venture capital fund, providing seed capital to nascent bioscience, plant science, and life science companies. It focuses on developing innovative technologies and scientific advancements. The fund’s activity bridges early financial gaps, enabling ventures to advance research, development, and market entry within these specialized sectors.
Established in 2010 by St. Louis County, with support from the St. Louis County Port Authority, the fund emerged from a recognized need for dedicated bioscience capital in the region. Its formation insightfully aimed to catalyze economic development and foster innovation by funding promising plant and life science entrepreneurs.
Its clientele encompasses early-stage companies and entrepreneurs across scientific disciplines in the St. Louis area. Helix Fund’s mission is to accelerate these bioscience and technology businesses, strengthening the regional economy. Its vision is to elevate St. Louis as a center for scientific advancement, fostering a dynamic life sciences ecosystem for future discoveries and job creation.
Helix Fund was founded in 2004 by David A. Helfand (Founder and CEO).
Key people at Helix Fund.
Helix Fund has 2 tracked investments across 2 companies. The latest tracked deal is $840K Seed in Graematter in May 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 21, 2013 | Graematter | $840K Seed | Biogenerator | Missouri Technology Corporation, ST. Louis Arch Angels, Washington University IN ST. Louis |
| Sep 17, 2012 | Confluence Life Sciences | $4.0M Series A | Danny Janiak | Biogenerator, Missouri Technology Corporation |